Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Gao HanlinChief Scientific Officer
|
GrantCommon Stock | 22,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 4 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 991,615 F4 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Gao HanlinChief Scientific Officer
|
GrantCommon Stock | 12,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 3 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 968,809 F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Gao HanlinChief Scientific Officer
|
GrantCommon Stock | 4,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 2 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 956,047 F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
GrantCommon Stock | 31,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 8 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,195 F8 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 15,095 | $23.09 | $348,543.55 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 7 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,013 F7 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 8,456 | $23.09 | $195,249.04 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 6 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,108 F6 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 3,241 | $23.09 | $74,834.69 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 5 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,564 F5 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
GrantCommon Stock | 26,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 4 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,805 F4 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
GrantCommon Stock | 14,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 3 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,132 F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
GrantCommon Stock | 5,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 2 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,206 F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 69,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 8 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 921,149 F8 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 31,760 | $23.09 | $733,338.40 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 7 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 851,855 F7 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 21,354 | $23.09 | $493,063.86 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 6 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,615 F6 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 10,230 | $23.09 | $236,210.70 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 5 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 904,969 F5 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 59,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 4 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915,199 F4 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 39,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 3 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 855,923 F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 19,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 816,121 F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:18 UTC |
Xie JianPresident and COO
|
Tax withholdingCommon Stock | 655 | $23.01 | $15,071.55 |
DisclosureSEC source: 0001193125-26-072640 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,383 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:17 UTC |
Gao HanlinChief Scientific Officer
|
Tax withholdingCommon Stock | 403 | $23.01 | $9,273.03 |
DisclosureSEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 951,156 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:18 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 661 | $23.01 | $15,209.61 |
DisclosureSEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,485 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:17 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 2,167 | $23.01 | $49,862.67 |
DisclosureSEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 797,054 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 22:02 UTC |
Xie JianPresident and COO
|
Tax withholdingCommon Stock | 4,711 | $27.53 | $129,693.83 |
DisclosureSEC source: 0001193125-26-027402 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,038 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 22:02 UTC |
Gao HanlinChief Scientific Officer
|
Tax withholdingCommon Stock | 1,331 | $27.53 | $36,642.43 |
DisclosureSEC source: 0001193125-26-027405 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 951,559 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 22:01 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 3,004 | $27.53 | $82,700.12 |
DisclosureSEC source: 0001193125-26-027397 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,146 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:04 UTC |
Xie JianPresident and COO
|
SaleCommon Stock | 1,140 | $28.33 | $32,298.25 |
DisclosureSEC source: 0001193125-25-306921 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,749 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022. F2 · price: The shares were sold in multiple transactions at prices ranging from $28.27 to $28.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:04 UTC |
Gao HanlinChief Scientific Officer
|
SaleCommon Stock | 1,075 | $28.33 | $30,456.69 |
DisclosureSEC source: 0001193125-25-306920 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 952,890 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022. F2 · price: The shares were sold in multiple transactions at prices ranging from $28.27 to $28.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:04 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 1,131 | $28.52 | $32,256.12 |
DisclosureSEC source: 0001193125-25-306924 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,150 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 02:14 UTC |
Xie JianPresident and COO
|
SaleCommon Stock | 1,198 | $29.57 | $35,424.26 |
DisclosureSEC source: 0001193125-25-304294 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 337,889 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. F2 · price: The shares were sold in multiple transactions at prices ranging from $29.45 to $29.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 02:14 UTC |
Gao HanlinChief Scientific Officer
|
SaleCommon Stock | 943 | $29.57 | $27,884.04 |
DisclosureSEC source: 0001193125-25-304293 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 953,965 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. F2 · price: The shares were sold in multiple transactions at prices ranging from $29.45 to $29.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 00:00 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 1,166 | $30.15 | $35,154.90 |
DisclosureSEC source: 0001193125-25-304201 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,281 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 00:00 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 2,944 | $30.15 | $88,761.60 |
DisclosureSEC source: 0001193125-25-304200 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 799,221 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:30 UTC |
Xie JianPresident and COO
|
SaleCommon Stock | 681 | $30.47 | $20,752.11 |
DisclosureSEC source: 0001193125-25-297323 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,087 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. F2 · price: The shares were sold in multiple transactions at prices ranging from $30.33 to $30.62, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:30 UTC |
Gao HanlinChief Scientific Officer
|
SaleCommon Stock | 535 | $30.47 | $16,303.06 |
DisclosureSEC source: 0001193125-25-297321 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 954,908 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. F2 · price: The shares were sold in multiple transactions at prices ranging from $30.33 to $30.62, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 23, 2025 Filed Nov 25, 2025 21:30 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 2,116 | $30.00 | $63,480.00 |
DisclosureSEC source: 0001193125-25-297327 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 802,165 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| November 23, 2025 Filed Nov 25, 2025 21:30 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 671 | $30.00 | $20,130.00 |
DisclosureSEC source: 0001193125-25-297326 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,447 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:30 UTC |
Xie JianPresident and COO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-291451 · ownership.xml · nonDerivative · entry 2 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,768 F3 · shares: Reflects shares transferred as a gift to the James and Karena Xie Family Foundation (the "Foundation"), of which, the reporting person is the president and has voting and investment power over all securities owned by the foundation. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:30 UTC |
Xie JianPresident and COO
|
SaleCommon Stock | 10,000 | $29.10 | $290,983.00 |
DisclosureSEC source: 0001193125-25-291451 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,768 F1 · shares: The shares were sold by the reporting person for year-end tax planning. F2 · price: The shares were sold in multiple transactions at prices ranging from $29.07 to $29.1985, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| October 26, 2025 Filed Oct 28, 2025 21:20 UTC |
Xie JianPresident and COO
|
Tax withholdingCommon Stock | 4,353 | $23.74 | $103,340.22 |
DisclosureSEC source: 0001193125-25-253871 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,768 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Read SEC document |
| October 26, 2025 Filed Oct 28, 2025 21:20 UTC |
Gao HanlinChief Scientific Officer
|
Tax withholdingCommon Stock | 1,642 | $23.74 | $38,981.08 |
DisclosureSEC source: 0001193125-25-253873 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955,443 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Read SEC document |
| October 26, 2025 Filed Oct 28, 2025 21:20 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 2,743 | $23.74 | $65,118.82 |
DisclosureSEC source: 0001193125-25-253872 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,118 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Read SEC document |
| September 03, 2025 Filed Sep 3, 2025 21:33 UTC |
Xie JianPresident and COO
|
SaleCommon Stock | 1,128 | $22.03 | $24,846.12 |
DisclosureSEC source: 0001819718-25-000022 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,121 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022. F2 · price: The shares were sold in multiple transactions at prices ranging from $21.92 to $22.175, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| September 03, 2025 Filed Sep 3, 2025 21:33 UTC |
Gao HanlinChief Scientific Officer
|
SaleCommon Stock | 1,063 | $22.03 | $23,414.38 |
DisclosureSEC source: 0001684532-25-000014 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 957,085 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022. F2 · price: The shares were sold in multiple transactions at prices ranging from $21.92 to $22.175, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 21:31 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 1,131 | $22.17 | $25,074.27 |
DisclosureSEC source: 0001253820-25-000008 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,861 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022. Read SEC document |
| August 27, 2025 Filed Aug 28, 2025 22:55 UTC |
Xie JianPresident and COO
|
SaleCommon Stock | 1,199 | $21.48 | $25,760.16 |
DisclosureSEC source: 0001819718-25-000018 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,249 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. F2 · price: The shares were sold in multiple transactions at prices ranging from $21.28 to $21.66, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 27, 2025 Filed Aug 28, 2025 22:55 UTC |
Gao HanlinChief Scientific Officer
|
SaleCommon Stock | 943 | $21.48 | $20,260.07 |
DisclosureSEC source: 0001684532-25-000010 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 958,148 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. F2 · price: The shares were sold in multiple transactions at prices ranging from $21.28 to $21.66, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 22:55 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 2,944 | $21.47 | $63,207.68 |
DisclosureSEC source: 0001302110-25-000006 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 804,281 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 22:55 UTC |
Kim PaulCFO and Treasurer
|
Tax withholdingCommon Stock | 1,166 | $21.47 | $25,034.02 |
DisclosureSEC source: 0001253820-25-000006 · ownership.xml · nonDerivative · entry 1 Kim Paul · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 337,992 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024. Read SEC document |
| August 25, 2025 Filed Aug 26, 2025 23:13 UTC |
Xie JianPresident and COO
|
SaleCommon Stock | 696 | $21.50 | $14,965.11 |
DisclosureSEC source: 0001819718-25-000008 · ownership.xml · nonDerivative · entry 1 Xie Jian · CIK 0001819718 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,448 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. F2 · price: The shares were sold in multiple transactions at prices ranging from $21.46 to $21.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 25, 2025 Filed Aug 26, 2025 23:10 UTC |
Gao HanlinChief Scientific Officer
|
SaleCommon Stock | 548 | $21.50 | $11,782.88 |
DisclosureSEC source: 0001684532-25-000005 · ownership.xml · nonDerivative · entry 1 Gao Hanlin · CIK 0001684532 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 959,091 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. F2 · price: The shares were sold in multiple transactions at prices ranging from $21.46 to $21.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 23, 2025 Filed Aug 26, 2025 23:12 UTC |
Hsieh MingDirector · Chief Executive Officer · 10% owner
|
Tax withholdingCommon Stock | 2,115 | $21.77 | $46,043.55 |
DisclosureSEC source: 0001302110-25-000004 · ownership.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,225 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.